Without access to harm reduction, PWUD are potentially at greater risk of acquiring blood-borne viruses
Pandemic response measures such as physical distancing and social isolation have disrupted the healthcare and support services that people who use or have used substances and their communities typically rely on.
This is 1 of 6 guidance documents, developed by CRISM at the request of federal governemnt. Collectively, the 6 documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID-19 pandemic
This document is 1 of 6 guidance documents developed by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID-19 pandemic.
COVID-19 pandemic compounds an ongoing public health crisis. There is a heightened need to reduce avoidable pressures on healthcare systems and support people who use opioids.
Guidance for service providers on how to alter harm reduction practices during pandemic to reduce spread of COVID-19 | Alberta Health Service COVID guidance
Business and border closures, physical distancing and other changes are affecting the illegal drug supply in several ways
Measures implemented to prevent the spread of COVID-19 are having a mixed impact on the drug supply chain
Guidance on making and wearing protective face coverings to slow the spread of COVID-19